IGC Pharma, Inc. (IGC)
NYSEAMERICAN: IGC · Real-Time Price · USD
0.342
+0.009 (2.68%)
Nov 21, 2024, 11:24 AM EST - Market open
IGC Pharma Employees
IGC Pharma had 67 employees as of March 31, 2024. The number of employees increased by 6 or 9.84% compared to the previous year.
Employees
67
Change (1Y)
6
Growth (1Y)
9.84%
Revenue / Employee
$17,657
Profits / Employee
-$187,597
Market Cap
26.50M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| DarioHealth | 294 |
| Pluri | 118 |
| Surrozen | 42 |
| GlycoMimetics | 35 |
| Daré Bioscience | 26 |
| GeoVax Labs | 17 |
| Lipocine | 17 |
| Akari Therapeutics, | 12 |
IGC News
- 7 days ago - IGC Pharma Reports Second Quarter Fiscal 2025 Results, Showcasing Progress in Its Alzheimer's Pipeline - Accesswire
- 15 days ago - IGC Pharma Announces Publication of IMS Spotlight Interview Highlighting Strategic Expansion in Alzheimer's and Weight Loss Therapies - Accesswire
- 5 weeks ago - IGC Pharma Announces Patient Enrollment at Toronto's Baycrest in Phase 2 Trial Investigating IGC-AD1 - Accesswire
- 7 weeks ago - IGC Pharma Wins 2 Prizes in Phase 1 of National Institutes of Health's AI PREPARE Challenge - Accesswire
- 2 months ago - IGC Pharma Announces Additional Data Supporting IGC-AD1 as an Alzheimer's Treatment - Business Wire
- 2 months ago - IGC Pharma Advances IGC-AD1 Toward Clinical Trials as a Potential anti-Amyloid Plaque Treatment for Alzheimer's Disease - Business Wire
- 3 months ago - IGC Pharma Announces Research Demonstrating New Molecule IGC-1C Targets Tau Protein in Alzheimer's Disease - Business Wire
- 3 months ago - IGC Pharma Reports First Quarter Fiscal 2025 Results - Business Wire